Managing immune dysregulation resulting from immune checkpoint inhibitors: impact of the ASCO guidelines and key take-homes for immunologists

Research output: Contribution to journalEditorialpeer-review

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)211-213
Number of pages3
JournalExpert Review of Clinical Immunology
Volume15
Issue number3
DOIs
StatePublished - Mar 4 2019

Keywords

  • Cancer immunotherapy
  • clinical practice guidelines
  • immune checkpoint inhibitors
  • immune-related adverse events
  • toxicity

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this